Walter Reed Army Institute of Research, Center for Military Psychiatry and Neuroscience , Branch of Brain Trauma Neuroprotection and Neurorestoration, Silver Spring, Maryland.
J Neurotrauma. 2014 Mar 1;31(5):505-14. doi: 10.1089/neu.2013.2965.
Abstract Blood-brain barrier (BBB) disruption is a pathological hallmark of severe traumatic brain injury (TBI) and is associated with neuroinflammatory events contributing to brain edema and cell death. The goal of this study was to elucidate the profile of BBB disruption after penetrating ballistic-like brain injury (PBBI) in conjunction with changes in neuroinflammatory markers. Brain uptake of biotin-dextran amine (BDA; 3 kDa) and horseradish peroxidase (HRP; 44 kDa) was evaluated in rats at 4 h, 24 h, 48 h, 72 h, and 7 days post-PBBI and compared with the histopathologic and molecular profiles for inflammatory markers. BDA and HRP both displayed a uniphasic profile of extravasation, greatest at 24 h post-injury and which remained evident out to 48 h for HRP and 7 days for BDA. This profile was most closely associated with markers for adhesion (mRNA for intercellular adhesion molecule-1) and infiltration of peripheral granulocytes (mRNA for matrix metalloproteinase-9 [MMP-9] and myeloperoxidase staining). Improvement of BBB dysfunction coincided with increased expression of markers implicated in tissue remodeling and repair. The results of this study reveal a uniphasic and gradient opening of the BBB after PBBI and suggest MMP-9 and resident inflammatory cell activation as candidates for future neurotherapeutic intervention after PBBI.
摘要血脑屏障(BBB)破坏是严重创伤性脑损伤(TBI)的病理标志,与导致脑水肿和细胞死亡的神经炎症事件有关。本研究的目的是阐明穿透性弹道样脑损伤(PBBI)后 BBB 破坏的情况,并结合神经炎症标志物的变化进行研究。在 PBBI 后 4 小时、24 小时、48 小时、72 小时和 7 天时,通过脑摄取生物素-葡聚糖胺(BDA;3 kDa)和辣根过氧化物酶(HRP;44 kDa)评估大鼠的 BBB 破坏情况,并与炎症标志物的组织病理学和分子特征进行比较。BDA 和 HRP 的外渗呈单相特征,在损伤后 24 小时达到峰值,HRP 持续到 48 小时,BDA 则持续到 7 天。这一特征与粘附标志物(细胞间黏附分子-1 的 mRNA)和外周粒细胞浸润标志物(基质金属蛋白酶-9 [MMP-9]的 mRNA 和髓过氧化物酶染色)最为密切相关。BBB 功能障碍的改善与参与组织重塑和修复的标志物表达增加相一致。这项研究的结果揭示了 PBBI 后 BBB 的单相和梯度开放,并表明 MMP-9 和固有炎症细胞的激活可能是 PBBI 后神经治疗干预的候选靶点。